BIOPHARMA DEVELOPMENT AI BY BCG X
LIVE

Serial Number

98919023

Owner

The Boston Consulting Group, Inc.

Attorney

Michael Geller

Filing Date

Dec 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIOPHARMA DEVELOPMENT AI BY BCG X Trademark

Serial Number: 98919023

BIOPHARMA DEVELOPMENT AI BY BCG X is a trademark filed by The Boston Consulting Group, Inc. on December 23, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

The Boston Consulting Group, Inc. (2 trademarks)

200 Pier 4 Boulevard, Floor 10
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

December 23, 2024

Registration Date

Not Registered

Published for Opposition

July 22, 2025

Goods & Services

Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; consulting services regarding cost containment in the field of clinical trials

Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, optimizing resource utilization, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2026 EXRA
SOU EXTENSION 2 GRANTED
Aug 21, 2026 EX2G
SOU EXTENSION 2 FILED
Aug 21, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 21, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 17, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 16, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 16, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 16, 2026 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 20, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2026 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 22, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 22, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 15, 2025 CNRT
ASSIGNED TO EXAMINER
May 9, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 12, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2025 NWOS
NEW APPLICATION ENTERED
Dec 23, 2024 NWAP